ImagineAR Provides Corporate Update

• On April 10, 2026, ImagineAR announced a temporary suspension of active operations for its augmented reality platform to preserve capital.
• The company stated it will focus on intellectual property portfolio expansion and licensing rather than direct product sales during this pause.
• On April 8, 2026, the U.S. District Court ruled that four of ImagineAR's asserted patents were invalid and dismissed the infringement claim against Niantic.
• Management intends to appeal the patent ruling but confirmed a director resigned following the legal setback.
• In December 2025, the company completed a $350,000 non-brokered private placement intended for working capital and operations.
• Also in December 2025, a major client (1000005450 Ontario Inc.) terminated agreements for the Niagara Immersive Center project citing economic conditions and financing risks.

• The suspension of active operations is a significant deviation from the growth narrative established during the November/December 2025 financings, which promised to "accelerate product development."
• The invalidation of core patents by a U.S. District Court fundamentally undermines the company's primary asset protection strategy and potential licensing revenue model.
• The combination of operational pause and legal defeat suggests the current business model is not generating sufficient traction or defensibility to justify continued active spending.
• Capital raised in late 2025 ($350,000) appears insufficient to sustain operations through a pivot to licensing without further dilution or revenue generation.
• The resignation of a board director coinciding with the litigation loss indicates internal governance concerns or strategic disagreement regarding the legal defense.

• Company: ImagineAR Inc. operates an augmented reality platform described as "AR-as-a-Service."
• Flagship Project: The Niagara Immersive Center was a key commercial deployment that has now been terminated by the client due to economic conditions, not technology deficiencies.
• Current Status: Active development and operations are paused; focus shifted to IP portfolio management and licensing negotiations.
• Technology: Relied on four specific U.S. Patents (Nos. 10,946,284; 11,484,284; 11,666,827; 12,070,691) which were recently ruled invalid by a court.